The zoom webinar QUALITOP: Workshop for stakeholders  will take place on Friday 15th October 2021 from 10:00h to 11:30h CEST.

The event is specifically designed for stakeholders in order to give them an overview on the main activities that have been undertaken, as well as, disseminate some of the main results.

You can register by clicking on this link.

QUALITOP aims at developing a European immunotherapy-specific open Smart Digital Platform and using big data analysis, artificial intelligence, and simulation modelling approaches. This will enable collecting and aggregating efficiently real-world data to monitor health status and QoL of cancer patients given immunotherapy.

Through causal inference analyses, QUALITOP will identify the determinants of health status regarding IR-AEs and define patient profiles in a real-world context. For this, heterogeneous data sources (big data), both retrospective and prospective –collected for QUALITOP from clinical centres in four EU countries—will integrate lifestyle, genetic, and psychosocial determinants of QoL. Using machine learning approaches, QUALITOP will provide “real-time” recommendations stemming from patient profiles and feedbacks via the Smart Digital Platform. Furthermore, an increased visibility on patients’ behaviour, a better IR-AEs prediction, and an improvement of care coordination will help analysing through simulation modelling approaches the gain in cost-effectiveness. Guidelines will be issued over the short and long-term.

• Delphine Maucort-Boulch, project coordinator

• Pr. Stéphane Dalle, Hospices Civils de Lyon

• Dr. Clémence Leyrat, London School of Hygiene & Tropical Medicine

• Pr. Mohand-Saïd Hacid, Université Claude Bernard Lyon 1

Debate

• Luisa Pagano, moderator

• Luisa Pagano, moderator

Concluding remarks

• Delphine Maucort-Boulch, project coordinator